Investors and analysts have welcomed RLI’s significant outperformance of expectations in the third quarter, while the insurer’s management provided bullish commentary on pricing during an earnings call.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: